Barinthus Biotherapeutics plc - American Depositary Shares BRNS 深 沪
等待开盘 11-10 09:30:00 美东时间
1.07
-0.120
-10.08%
华盛通- 最 高1.25
- 今 开1.25
- 成交量 11.70万股
- 最 低 1.05
- 昨 收 1.19
- 总市值 4316.32万
- 52周最高 2.92
- 市盈率 静 --
- 换手率 0.29%
- 52周最低 0.64
- 委 比 31.63%
- 总股本 4033.94万
- 历史最高 17.99
- 量 比 4.98
- 振 幅 16.81%
- 历史最低 0.64
- 每 手 1
- 风险率 0.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ChemDiv To Continue R&D Support As Clywedog Merges With Barinthus Therapeutics; Combined Entity To Trade Under Ticker CLYD On Nasdaq
ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry, computational, and clinical pharmacology support to Clywedog Therapeutics as the company
10-24 23:05
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
10-17 11:58
Barinthus Biotherapeutics And Clywedog Therapeutics Enters Into A Definitive All-Stock Merger Agreement To Form Combined Company; Before Transaction Closes The Combined Company May Initiate Partial Tender Offer To Purchase Up To $27M Worth Of Its Outstanding Shares Held By Barinthus Bio Shareholders
Barinthus Biotherapeutics plc (NASDAQ:BRNS) ("Barinthus Bio"), an immunology and inflammation company focused on developing therapies that promote immune tolerance, and Clywedog Therapeutics, Inc. ("Clywedog"), a private
09-30 20:18
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Equillium (NASDAQ:EQ) shares moved upwards by 98.9% to $0.98 during Mo...
08-12 01:06
Barinthus Biotherapeutics GAAP EPS of -$0.52
Barinthus Biotherapeutics press release (NASDAQ:BRNS): Q2 GAAP EPS of -$0.52. As of June 30, 2025, cash, cash equivalents and restricted cash was $87.8 million, compared to $100.6 million as of March ...
08-07 23:13
Barinthus Biotherapeutics Q2 EPS $(0.52) Misses $(0.33) Estimate
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.33) by 57.58 percent. This is a 20.93 percent decrease over losses of $(0.43) per
08-07 20:12
Barinthus Biotherapeutics Q1 EPS $(0.49) Misses $(0.36) Estimate
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.36) by 36.11 percent. This is a 22.5 percent decrease over losses of $(0.40) per
05-07 21:20
Barinthus Biotherapeutics Restructures Leadership with New CFO
Barinthus Biotherapeutics ( ($BRNS) ) has issued an update. Barinthus Biotherap...
05-07 20:28
美股大行评级 | 高盛：上调Adaptive Biotechnologies评级至"买入"，目标价从8美元升至9美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1110125309827231744.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Amprius Technologies(AMPX)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 韦德布什：维持Monte Rosa Therapeutics(GLUE)"跑
03-24 07:31
H.C. Wainwright Sticks to Its Buy Rating for Barinthus Biotherapeutics (BRNS)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Barinthus Biotherape...
03-21 18:46
